eGFR Threshold for Metformin Initiation

Clear eGFR-Based Initiation Criteria

• The Kidney Disease: Improving Global Outcomes (KDIGO) guidelines support metformin use at eGFR ≥30 mL/min/1.73 m² for continuation of therapy with dose reduction, not necessarily new initiation 1, 2
• Metformin initiation is appropriate with standard starting doses when eGFR ≥45 mL/min/1.73 m² 1

Starting Doses When Initiation is Appropriate

• The American Diabetes Association recommends starting metformin at 500 mg twice daily or 850 mg once daily with meals when eGFR is ≥45 mL/min/1.73 m² 1, 3
• The extended-release formulation can be started at 500 mg once daily with the evening meal when eGFR is ≥45 mL/min/1.73 m² 1

Mandatory Monitoring Requirements

• The National Kidney Foundation recommends monitoring eGFR at least annually in all patients on metformin 1
• The frequency of eGFR monitoring should be increased to every 3-6 months when eGFR falls below 60 mL/min/1.73 m² 1, 3, 4

Critical Safety Considerations

• The FDA states that metformin is absolutely contraindicated in patients with eGFR <30 mL/min/1.73 m² 1, 2, 4
• The European Association for the Study of Diabetes recommends temporary discontinuation of metformin for iodinated contrast procedures, surgical procedures with restricted oral intake, and acute illnesses that increase the risk of acute kidney injury 1

Alternative Agents When Metformin Cannot Be Initiated

• The American College of Cardiology recommends considering GLP-1 receptor agonists, DPP-4 inhibitors, insulin, or SGLT2 inhibitors as alternative agents when metformin initiation is not recommended due to eGFR 30-44 mL/min/1.73 m² 1, 2, 4